Research progress of laparoscopic sleeve gastrectomy in treatment of obesity and its comorbidities_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

WU Kaiqi ^1,2 , CAO Xinling ^1,2 , YAO Gang ¹ , LI Tao ¹ ,  ZHAO Jinming ¹

1. Department of Laparoscopic Surgery and Liver Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, P. R. China;
2. State Key Laboratory of Causes and Preventions of High Incidence in Central Asia, Urumqi 830054, P. R. China;

Corresponding author：

ZHAO Jinming, Email: zjmjswyyx@163.com

Keywords：

laparoscopic sleeve gastrectomy; obesity; comorbidities

DOI：

10.7507/1007-9424.202010063

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To explore the effect of laparoscopic sleeve gastrectomy (LSG) on obesity and its comorbidities.Method The literatures about LSG in the treatment of obesity and its comorbidities were collected and summarized.Results LSG could not only effectively reduce the weight of patients with obesity, but also obviously alleviate comorbidities related to obesity, such as type 2 diabetes mellitus, obstructive sleep apnea syndrome, polycystic ovary syndrome, essential hypertension, hyperlipidemia, and so on.Conclusions LSG has a definite and effective long-term weight loss effect, which is equal to other common weight loss methods. It has been recognized by more and more patients and clinicians because it has advantages of simple operation, safety, high efficiency and fewer complications. However, therapeutic effects of some comorbidities, such as gastroesophageal reflux disease, are still controversial and need further tobe studied.

Citation： WU Kaiqi, CAO Xinling, YAO Gang, LI Tao, ZHAO Jinming. Research progress of laparoscopic sleeve gastrectomy in treatment of obesity and its comorbidities. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2021, 28(8): 1098-1102. doi: 10.7507/1007-9424.202010063 Copy

1.	中华医学会内分泌学分会肥胖学组. 中国成人肥胖症防治专家共识. 中华内分泌代谢杂志, 2011, 27(9): 711-717.
2.	朱莹, 徐宁. 2006–2015年我国成人超重和肥胖长期变化趋势分析. 中国药物与临床, 2020, 20(11): 1803-1804.
3.	de Wit L, Luppino F, van Straten A, et al. Depression and obesity: a meta-analysis of community-based studies. Psychiatry Res, 2010, 178(2): 230-235.
4.	Zhang Y, Wang J, Sun X, et al. Laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass for morbid obesity and related comorbidities: a meta-analysis of 21 studies. Obes Surg, 2015, 25(1): 19-26.
5.	Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg, 1998, 8(3): 267-282.
6.	Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg, 2017, 27(9): 2279-2289.
7.	梁辉. 袖状胃切除术与胃旁路术优缺点概述. 国际外科学杂志, 2019, 46(4): 223-225.
8.	Wittgrove AC, Clark GW, Tremblay LJ. Laparoscopic gastric bypass, Roux-en-Y: preliminary report of five cases. Obes Surg, 1994, 4(4): 353-357.
9.	Cadière GB, Bruyns J, Himpens J, et al. Laparoscopic gastroplasty for morbid obesity. Br J Surg, 1994, 81(10): 1524.
10.	Deitel M, Crosby RD, Gagner M. The first international consensus summit for sleeve gastrectomy (SG), New York City, October 25–27, 2007. Obes Surg, 2008, 18(5): 487-496.
11.	张辰, 赵宏志, 钱东, 等. 腹腔镜胃旁路术与药物治疗肥胖合并2型糖尿病疗效比较分析. 中国实用外科杂志, 2016, 36(10): 1096-1100.
12.	Aminian A. Bariatric procedure selection in patients with type 2 diabetes: choice between Roux-en-Y gastric bypass or sleeve gastrectomy. Surg Obes Relat Dis, 2020, 16(2): 332-339.
13.	Angrisani L. 2014: The year of the sleeve supremacy. Obes Surg, 2017, 27(6): 1626-1627.
14.	Sasaki A, Wakabayashi G, Yonei Y. Current status of bariatric surgery in Japan and effectiveness in obesity and diabetes. J Gastroenterol, 2014, 49(1): 57-63.
15.	Reinhold RB. Critical analysis of long term weight loss following gastric bypass. Surg Gynecol Obstet, 1982, 155(3): 385-394.
16.	Gil-Rendo A, Muñoz-Rodríguez JR, Domper Bardají F, et al. Laparoscopic sleeve gastrectomy for high-risk patients in a monocentric series: long-term outcomes and predictors of success. Obes Surg, 2019, 29(11): 3629-3637.
17.	Toolabi K, Sarkardeh M, Vasigh M, et al. Comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy on weight loss, weight regain, and remission of comorbidities: a 5 years of follow-up study. Obes Surg, 2020, 30(2): 440-445.
18.	Himpens J, Dapri G, Cadière GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg, 2006, 16(11): 1450-1456.
19.	Blumenfeld O, Beglaibter N, Geron N, et al. Comparative effectiveness of laparoscopic adjustable gastric banding vs laparoscopic sleeve gastrectomy in adolescents—a National Registry-Based Study. Obes Surg, 2020, 30(1): 296-303.
20.	Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet, 2015, 386(9997): 964-973.
21.	Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med, 2017, 376(7): 641-651.
22.	Khorgami Z, Shoar S, Saber AA, et al. Outcomes of bariatric surgery versus medical management for type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Obes Surg, 2019, 29(3): 964-974.
23.	Mizera M, Wysocki M, Bartosiak K, et al. Type 2 diabetes remission 5 years after laparoscopic sleeve gastrectomy: multicenter cohort study. Obes Surg, 2021, 31(3): 980-986.
24.	Salminen P, Helmiö M, Ovaska J, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: The SLEEVEPASS randomized clinical trial. JAMA, 2018, 319(3): 241-254.
25.	朱江帆. 从上游探索减重手术治疗代谢综合征的机制. 中华消化外科杂志, 2017, 16(6): 559-561.
26.	Zhu J, Gupta R, Safwa M. The mechanism of metabolic surgery: gastric center hypothesis. Obes Surg, 2016, 26(7): 1639-1641.
27.	Tutuian R. Obesity and GERD: pathophysiology and effect of bariatric surgery. Curr Gastroenterol Rep, 2011, 13(3): 205-212.
28.	Nilsson M, Lundegårdh G, Carling L, et al. Body mass and reflux oesophagitis: an oestrogen-dependent association? Scand J Gastroenterol, 2002, 37(6): 626-630.
29.	Chen J, Brady P. Gastroesophageal reflux disease: pathophysiology, diagnosis, and treatment. Gastroenterol Nurs, 2019, 42(1): 20-28.
30.	Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med, 2005, 143(3): 199-211.
31.	Docimo S, Rahmana U, Bates A, et al. Concomitant Hiatal hernia repair is more common in laparoscopic sleeve gastrectomy than during laparoscopic Roux-en-Y gastric bypass: an analysis of 130 772 cases. Obes Surg, 2019, 29(2): 744-746.
32.	DuPree CE, Blair K, Steele SR, et al. Laparoscopic sleeve gastrectomy in patients with preexisting gastroesophageal reflux disease: a national analysis. JAMA Surg, 2014, 149(4): 328-334.
33.	Coupaye M, Gorbatchef C, Calabrese D, et al. Gastroesophageal reflux after sleeve gastrectomy: a prospective mechanistic study. Obes Surg, 2018, 28(3): 838-845.
34.	Rebecchi F, Allaix ME, Giaccone C, et al. Gastroesophageal reflux disease and laparoscopic sleeve gastrectomy: a physiopathologic evaluation. Ann Surg, 2014, 260(5): 909-914.
35.	Pallati PK, Shaligram A, Shostrom VK, et al. Improvement in gastroesophageal reflux disease symptoms after various bariatric procedures: review of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis, 2014, 10(3): 502-507.
36.	Biter LU, van Buuren MMA, Mannaerts GHH, et al. Quality of life 1 year after laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass: a randomized controlled trial focusing on gastroesophageal reflux disease. Obes Surg, 2017, 27(10): 2557-2565.
37.	Gorodner V, Viscido G, Signorini F, et al. Gastroesophageal reflux disease and morbid obesity: evaluation and treatment. Updates Surg, 2018, 70(3): 331-337.
38.	Gu L, Chen B, Du N, et al. Relationship between bariatric surgery and gastroesophageal reflux disease: a systematic review and meta-analysis. Obes Surg, 2019, 29(12): 4105-4113.
39.	Gasa M, Salord N, Fortuna AM, et al. Optimizing screening of severe obstructive sleep apnea in patients undergoing bariatric surgery. Surg Obes Relat Dis, 2013, 9(4): 539-546.
40.	Kolotkin RL, LaMonte MJ, Walker JM, et al. Predicting sleep apnea in bariatric surgery patients. Surg Obes Relat Dis, 2011, 7(5): 605-610.
41.	Del Genio G, Limongelli P, Del Genio F, et al. Sleeve gastrectomy improves obstructive sleep apnea syndrome (OSAS): 5 year longitudinal study. Surg Obes Relat Dis, 2016, 12(1): 70-74.
42.	Timmerman M, Basille D, Basille-Fantinato A, et al. Short-term assessment of obstructive sleep apnea syndrome remission rate after sleeve gastrectomy: a cohort study. Obes Surg, 2019, 29(11): 3690-3697.
43.	Amin R, Simakajornboon N, Szczesniak R, et al. Early improvement in obstructive sleep apnea and increase in orexin levels after bariatric surgery in adolescents and young adults. Surg Obes Relat Dis, 2017, 13(1): 95-100.
44.	Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol, 2004, 18(5): 671-683.
45.	Ehrmann DA. Polycystic ovary syndrome. N Engl J Med, 2005, 352(12): 1223-1236.
46.	Hoeger KM, Oberfield SE. Do women with PCOS have a unique predisposition to obesity? Fertil Steril, 2012, 97(1): 13-17.
47.	Domecq JP, Prutsky G, Mullan RJ, et al. Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis. J Clin Endocrinol Metab, 2013, 98(12): 4655-4663.
48.	Crosignani PG, Colombo M, Vegetti W, et al. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod, 2003, 18(9): 1928-1932.
49.	Eid GM, McCloskey C, Titchner R, et al. Changes in hormones and biomarkers in polycystic ovarian syndrome treated with gastric bypass. Surg Obes Relat Dis, 2014, 10(5): 787-791.
50.	Wang K, Jiang Q, Zhi Y, et al. Contrasting sleeve gastrectomy with lifestyle modification therapy in the treatment of polycystic ovary syndrome. J Laparoendosc Adv Surg Tech A, 2015, 25(6): 493-498.
51.	Nocca D, Loureiro M, Skalli EM, et al. Five-year results of laparoscopic sleeve gastrectomy for the treatment of severe obesity. Surg Endosc, 2017, 31(8): 3251-3257.
52.	Graham C, Switzer N, Reso A, et al. Sleeve gastrectomy and hypertension: a systematic review of long-term outcomes. Surg Endosc, 2019, 33(9): 3001-3007.
53.	Catapano AL, Graham I, De Backer G, et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J, 2016, 37(39): 2999-3058.
54.	Bays H, Kothari SN, Azagury DE, et al. Lipids and bariatric procedures Part 2 of 2: scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA). Surg Obes Relat Dis, 2016, 12(3): 468-495.
55.	Vigilante A, Signorini F, Marani M, et al. Impact on dyslipidemia after laparoscopic sleeve gastrectomy. Obes Surg, 2018, 28(10): 3111-3115.

1. 中华医学会内分泌学分会肥胖学组. 中国成人肥胖症防治专家共识. 中华内分泌代谢杂志, 2011, 27(9): 711-717.
2. 朱莹, 徐宁. 2006–2015年我国成人超重和肥胖长期变化趋势分析. 中国药物与临床, 2020, 20(11): 1803-1804.
3. de Wit L, Luppino F, van Straten A, et al. Depression and obesity: a meta-analysis of community-based studies. Psychiatry Res, 2010, 178(2): 230-235.
4. Zhang Y, Wang J, Sun X, et al. Laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass for morbid obesity and related comorbidities: a meta-analysis of 21 studies. Obes Surg, 2015, 25(1): 19-26.
5. Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg, 1998, 8(3): 267-282.
6. Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg, 2017, 27(9): 2279-2289.
7. 梁辉. 袖状胃切除术与胃旁路术优缺点概述. 国际外科学杂志, 2019, 46(4): 223-225.
8. Wittgrove AC, Clark GW, Tremblay LJ. Laparoscopic gastric bypass, Roux-en-Y: preliminary report of five cases. Obes Surg, 1994, 4(4): 353-357.
9. Cadière GB, Bruyns J, Himpens J, et al. Laparoscopic gastroplasty for morbid obesity. Br J Surg, 1994, 81(10): 1524.
10. Deitel M, Crosby RD, Gagner M. The first international consensus summit for sleeve gastrectomy (SG), New York City, October 25–27, 2007. Obes Surg, 2008, 18(5): 487-496.
11. 张辰, 赵宏志, 钱东, 等. 腹腔镜胃旁路术与药物治疗肥胖合并2型糖尿病疗效比较分析. 中国实用外科杂志, 2016, 36(10): 1096-1100.
12. Aminian A. Bariatric procedure selection in patients with type 2 diabetes: choice between Roux-en-Y gastric bypass or sleeve gastrectomy. Surg Obes Relat Dis, 2020, 16(2): 332-339.
13. Angrisani L. 2014: The year of the sleeve supremacy. Obes Surg, 2017, 27(6): 1626-1627.
14. Sasaki A, Wakabayashi G, Yonei Y. Current status of bariatric surgery in Japan and effectiveness in obesity and diabetes. J Gastroenterol, 2014, 49(1): 57-63.
15. Reinhold RB. Critical analysis of long term weight loss following gastric bypass. Surg Gynecol Obstet, 1982, 155(3): 385-394.
16. Gil-Rendo A, Muñoz-Rodríguez JR, Domper Bardají F, et al. Laparoscopic sleeve gastrectomy for high-risk patients in a monocentric series: long-term outcomes and predictors of success. Obes Surg, 2019, 29(11): 3629-3637.
17. Toolabi K, Sarkardeh M, Vasigh M, et al. Comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy on weight loss, weight regain, and remission of comorbidities: a 5 years of follow-up study. Obes Surg, 2020, 30(2): 440-445.
18. Himpens J, Dapri G, Cadière GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg, 2006, 16(11): 1450-1456.
19. Blumenfeld O, Beglaibter N, Geron N, et al. Comparative effectiveness of laparoscopic adjustable gastric banding vs laparoscopic sleeve gastrectomy in adolescents—a National Registry-Based Study. Obes Surg, 2020, 30(1): 296-303.
20. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet, 2015, 386(9997): 964-973.
21. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med, 2017, 376(7): 641-651.
22. Khorgami Z, Shoar S, Saber AA, et al. Outcomes of bariatric surgery versus medical management for type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Obes Surg, 2019, 29(3): 964-974.
23. Mizera M, Wysocki M, Bartosiak K, et al. Type 2 diabetes remission 5 years after laparoscopic sleeve gastrectomy: multicenter cohort study. Obes Surg, 2021, 31(3): 980-986.
24. Salminen P, Helmiö M, Ovaska J, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: The SLEEVEPASS randomized clinical trial. JAMA, 2018, 319(3): 241-254.
25. 朱江帆. 从上游探索减重手术治疗代谢综合征的机制. 中华消化外科杂志, 2017, 16(6): 559-561.
26. Zhu J, Gupta R, Safwa M. The mechanism of metabolic surgery: gastric center hypothesis. Obes Surg, 2016, 26(7): 1639-1641.
27. Tutuian R. Obesity and GERD: pathophysiology and effect of bariatric surgery. Curr Gastroenterol Rep, 2011, 13(3): 205-212.
28. Nilsson M, Lundegårdh G, Carling L, et al. Body mass and reflux oesophagitis: an oestrogen-dependent association? Scand J Gastroenterol, 2002, 37(6): 626-630.
29. Chen J, Brady P. Gastroesophageal reflux disease: pathophysiology, diagnosis, and treatment. Gastroenterol Nurs, 2019, 42(1): 20-28.
30. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med, 2005, 143(3): 199-211.
31. Docimo S, Rahmana U, Bates A, et al. Concomitant Hiatal hernia repair is more common in laparoscopic sleeve gastrectomy than during laparoscopic Roux-en-Y gastric bypass: an analysis of 130 772 cases. Obes Surg, 2019, 29(2): 744-746.
32. DuPree CE, Blair K, Steele SR, et al. Laparoscopic sleeve gastrectomy in patients with preexisting gastroesophageal reflux disease: a national analysis. JAMA Surg, 2014, 149(4): 328-334.
33. Coupaye M, Gorbatchef C, Calabrese D, et al. Gastroesophageal reflux after sleeve gastrectomy: a prospective mechanistic study. Obes Surg, 2018, 28(3): 838-845.
34. Rebecchi F, Allaix ME, Giaccone C, et al. Gastroesophageal reflux disease and laparoscopic sleeve gastrectomy: a physiopathologic evaluation. Ann Surg, 2014, 260(5): 909-914.
35. Pallati PK, Shaligram A, Shostrom VK, et al. Improvement in gastroesophageal reflux disease symptoms after various bariatric procedures: review of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis, 2014, 10(3): 502-507.
36. Biter LU, van Buuren MMA, Mannaerts GHH, et al. Quality of life 1 year after laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass: a randomized controlled trial focusing on gastroesophageal reflux disease. Obes Surg, 2017, 27(10): 2557-2565.
37. Gorodner V, Viscido G, Signorini F, et al. Gastroesophageal reflux disease and morbid obesity: evaluation and treatment. Updates Surg, 2018, 70(3): 331-337.
38. Gu L, Chen B, Du N, et al. Relationship between bariatric surgery and gastroesophageal reflux disease: a systematic review and meta-analysis. Obes Surg, 2019, 29(12): 4105-4113.
39. Gasa M, Salord N, Fortuna AM, et al. Optimizing screening of severe obstructive sleep apnea in patients undergoing bariatric surgery. Surg Obes Relat Dis, 2013, 9(4): 539-546.
40. Kolotkin RL, LaMonte MJ, Walker JM, et al. Predicting sleep apnea in bariatric surgery patients. Surg Obes Relat Dis, 2011, 7(5): 605-610.
41. Del Genio G, Limongelli P, Del Genio F, et al. Sleeve gastrectomy improves obstructive sleep apnea syndrome (OSAS): 5 year longitudinal study. Surg Obes Relat Dis, 2016, 12(1): 70-74.
42. Timmerman M, Basille D, Basille-Fantinato A, et al. Short-term assessment of obstructive sleep apnea syndrome remission rate after sleeve gastrectomy: a cohort study. Obes Surg, 2019, 29(11): 3690-3697.
43. Amin R, Simakajornboon N, Szczesniak R, et al. Early improvement in obstructive sleep apnea and increase in orexin levels after bariatric surgery in adolescents and young adults. Surg Obes Relat Dis, 2017, 13(1): 95-100.
44. Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol, 2004, 18(5): 671-683.
45. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med, 2005, 352(12): 1223-1236.
46. Hoeger KM, Oberfield SE. Do women with PCOS have a unique predisposition to obesity? Fertil Steril, 2012, 97(1): 13-17.
47. Domecq JP, Prutsky G, Mullan RJ, et al. Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis. J Clin Endocrinol Metab, 2013, 98(12): 4655-4663.
48. Crosignani PG, Colombo M, Vegetti W, et al. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod, 2003, 18(9): 1928-1932.
49. Eid GM, McCloskey C, Titchner R, et al. Changes in hormones and biomarkers in polycystic ovarian syndrome treated with gastric bypass. Surg Obes Relat Dis, 2014, 10(5): 787-791.
50. Wang K, Jiang Q, Zhi Y, et al. Contrasting sleeve gastrectomy with lifestyle modification therapy in the treatment of polycystic ovary syndrome. J Laparoendosc Adv Surg Tech A, 2015, 25(6): 493-498.
51. Nocca D, Loureiro M, Skalli EM, et al. Five-year results of laparoscopic sleeve gastrectomy for the treatment of severe obesity. Surg Endosc, 2017, 31(8): 3251-3257.
52. Graham C, Switzer N, Reso A, et al. Sleeve gastrectomy and hypertension: a systematic review of long-term outcomes. Surg Endosc, 2019, 33(9): 3001-3007.
53. Catapano AL, Graham I, De Backer G, et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J, 2016, 37(39): 2999-3058.
54. Bays H, Kothari SN, Azagury DE, et al. Lipids and bariatric procedures Part 2 of 2: scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA). Surg Obes Relat Dis, 2016, 12(3): 468-495.
55. Vigilante A, Signorini F, Marani M, et al. Impact on dyslipidemia after laparoscopic sleeve gastrectomy. Obes Surg, 2018, 28(10): 3111-3115.

Previous Article
Research progress on active surveillance of low-risk papillary thyroid microcarcinoma
Next Article
Research progress of DNA methylation change after bariatric surgery

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Research progress of laparoscopic sleeve gastrectomy in treatment of obesity and its comorbidities

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content